Quick Answer
Orthofix Medical Inc. reported Research And Development Expense of $65.85 million for the year ending 2025.
- Orthofix Medical Inc. showed a decrease of -10.6% in Research And Development Expense from 2024 to 2025.
- This data is from Orthofix Medical Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $7.38 million | Q1 2011: $6.05 million | Q2 2011: $6.23 million | Q3 2011: $5.98 million | Q1 2012: $7.05 million | Q2 2012: $9.25 million | Q3 2012: $6.86 million | Q1 2013: $5.74 million | Q2 2013: $8.55 million | Q3 2013: $6.36 million | Q1 2014: $5.93 million | Q2 2014: $6.31 million | Q3 2014: $6.57 million | Q1 2015: $5.85 million | Q2 2015: $6.45 million | Q3 2015: $6.52 million | Q1 2016: $7.64 million | Q2 2016: $6.80 million | Q3 2016: $6.86 million | Q1 2017: $7.42 million | Q2 2017: $6.89 million | Q3 2017: $6.94 million | Q1 2018: $6.94 million | Q2 2018: $7.89 million | Q3 2018: $9.60 million | Q1 2019: $9.23 million | Q2 2019: $8.98 million | Q3 2019: $7.98 million | Q1 2020: $9.96 million | Q2 2020: $8.77 million | Q3 2020: $9.96 million | Q1 2021: $10.90 million | Q2 2021: $13.12 million | Q3 2021: $12.36 million | Q1 2022: $11.21 million | Q2 2022: $12.76 million | Q3 2022: $11.94 million | Q1 2023: $23.31 million | Q2 2023: $19.42 million | Q3 2023: $18.56 million | Q1 2024: $19.49 million | Q2 2024: $18.05 million | Q3 2024: $17.29 million | Q1 2025: $19.77 million | Q2 2025: $15.93 million | Q3 2025: $14.77 million.
- Over the full 17 years of available data (2009 to 2025), Orthofix Medical Inc.'s Research And Development Expense has grown by 109.3%.
- Historical annual values: Fiscal year 2025: $65.85 million | Fiscal year 2024: $73.64 million | Fiscal year 2023: $80.23 million | Fiscal year 2022: $49.07 million | Fiscal year 2021: $49.62 million | Fiscal year 2020: $39.06 million | Fiscal year 2019: $34.64 million | Fiscal year 2018: $33.22 million | Fiscal year 2017: $29.70 million | Fiscal year 2016: $28.80 million | Fiscal year 2015: $26.39 million | Fiscal year 2014: $24.99 million | Fiscal year 2013: $26.77 million | Fiscal year 2012: $28.58 million | Fiscal year 2011: $22.86 million | Fiscal year 2010: $27.96 million | Fiscal year 2009: $31.46 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: